Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"B5S3K2V0G8"
journalStr:"Lancet (London, England)"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22B5S3K2V0G8%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (14)
1
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
2
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV) : a multicentre, randomised, controlled, phase 4 trial
enthalten in:
Lancet (London, England)
| 2021
von
Lazarus, R.
|
Baos, S.
|
Cappel-Porter, H.
| +128
Wird geladen...
3
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST) : a blinded, multicentre, randomised, controlled, phase 2 trial
enthalten in:
Lancet (London, England)
| 2021
von
Munro, A.
|
Janani, L.
|
Cornelius, V.
| +152
ErratumIn: Lancet. 2021 Dec 18;398(10318):2246. - PMID 34922669
Wird geladen...
4
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK : a substudy of two randomised controlled trials (COV001 and COV002)
enthalten in:
Lancet (London, England)
| 2021
von
Flaxman, A.
|
Marchevsky, N.
|
Jenkin, D.
| +135
CommentIn: Lancet. 2021 Sep 11;398(10304):933-935. - PMID 34480860
Wird geladen...
5
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial
enthalten in:
Lancet (London, England)
| 2021
von
Liu, X.
|
Shaw, R.
|
Stuart, A.
| +86
CommentIn: Lancet. 2021 Sep 4;398(10303):819-821. - PMID 34370969
Wird geladen...
6
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
enthalten in:
Lancet (London, England)
| 2021
von
Wall, E.
|
Wu, M.
|
Harvey, R.
| +21
Wird geladen...
7
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS) : a multicentre, open-label, randomised, controlled, phase 2 trial
enthalten in:
Lancet (London, England)
| 2021
von
Borobia, A.
|
Carcas, A.
|
Pérez-Olmeda, M.
| +124
CommentIn: Lancet. 2021 Jul 10;398(10295):94-95. - PMID 34181881
Wird geladen...
8
Heterologous prime-boost COVID-19 vaccination : initial reactogenicity data
enthalten in:
Lancet (London, England)
| 2021
von
Shaw, R.
|
Stuart, A.
|
Greenland, M.
| +4
CommentIn: Nature. 2021 May;593(7860):491. - PMID 34012131
Wird geladen...
9
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study
enthalten in:
Lancet (London, England)
| 2021
von
Vasileiou, E.
|
Simpson, C.
|
Shi, T.
| +29
CommentIn: Lancet. 2021 May 1;397(10285):1601-1603. - PMID 33901421
Wird geladen...
10
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7) : an exploratory analysis of a randomised controlled trial
enthalten in:
Lancet (London, England)
| 2021
von
Emary, K.
|
Golubchik, T.
|
Aley, P.
| +64
CommentIn: Lancet. 2021 Apr 10;397(10282):1326-1327. - PMID 33798497
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: B5S3K2V0G8
Filter aufheben
Zeitschrift: Lancet (London, England)
Medienart
14
Aufsätze
14
E-Artikel
14
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
B5S3K2V0G8
14
ChAdOx1 nCoV-19
Research Support, Non-U.S. Gov't
12
COVID-19 Vaccines
12
Journal Article
7
Randomized Controlled Trial
6
BNT162 Vaccine
6
N38TVC63NU
5
Clinical Trial, Phase II
5
Multicenter Study
2
Antibodies, Neutralizing
2
Antibodies, Viral
2
Comment
2
Immunoglobulin G
2
Letter
2
Spike Glycoprotein, Coronavirus
1
Clinical Trial, Phase III
1
Clinical Trial, Phase IV
1
Comparative Study
1
Influenza Vaccines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
14
Englisch
Haven't found what you're looking for?
Wird geladen...